Collectively, our study showed that elevated ICAM-4 levels increased the risks of ischemic stroke and CES, suggesting that ICAM-4 might be acted as a promising biomarker to identify high-risk individuals for active monitoring and early intervention of ischemic stroke. The gene discussed is ICAM4; the disease is ischemic stroke.